Endometrial stromal sarcoma (ESS) is an aggressive uterine sarcoma. We report a case of a large endometrial stromal sarcoma in a 42 year nulliparous woman with chronic kidney disease presenting with acute urinary retention and irregular per vaginal bleeding. Ultrasound and Doppler imaging revealed a heterogeneous mass in the endometrial cavity with internal vascularity. Magnetic resonance imaging (MRI) revealed a large lobulated mass in the endometrial cavity extending into the vagina, causing local mass effect. Multiple linear hypointense bands on magnetic resonance T2 weighted (T2wt) images were characteristic of ESS. MRI is a very useful imaging modality in characterizing the lesion and also for the staging. It is necessary to distinguish these tumors from benign as well as other uterine malignancies for better management. We also review relevant literature discussing imaging findings of ESS.
ABSTRACT Endometrial stromal sarcoma (ESS) is an aggressive uterine sarcoma. We report a case of a large endometrial stromal sarcoma in a 42 year nulliparous woman with chronic kidney disease presenting with acute urinary retention and irregular per vaginal bleeding. Ultrasound and Doppler imaging revealed a heterogeneous mass in the endometrial cavity with internal vascularity. Magnetic resonance imaging (MRI) revealed a large lobulated mass in the endometrial cavity extending into the vagina, causing local mass effect. Multiple linear hypointense bands on magnetic resonance T2 weighted (T2wt) images were characteristic of ESS. MRI is a very useful imaging modality in characterizing the lesion and also for the staging. It is necessary to distinguish these tumors from benign as well as other uterine malignancies for better management. We also review relevant literature discussing imaging findings of ESS.
CASE REPORT
A 42-year-old nulliparous, premenopausal woman with Chronic kidney disease (CKD) presented with acute urinary retention. She also gave a history of constipation since 1 month and irregular per vaginal bleeding since 3 months. Ultrasound of the abdomen and pelvis done 7 months back revealed thickened endometrium (~20mm). Patient refused further investigation of the uterine thickening at that time. There was no prior history of polycystic ovarian disease or use of hormonal therapy in the past. Clinical examination revealed a mass in the lower abdomen. Transabdominal Sonography showed a large, heterogeneously echogenic lesion (11 x 9 x 10cms) distending the endometrial cavity with extension into the cervix and vagina (Fig 1) . Internal vascularity was appreciated on Color Doppler (Fig 2) . There was compression of the urinary bladder and distal ureters causing bilateral hydroureteronephrosis (Fig 3) . Further imaging with MRI showed a large lobulated mass in the endometrial cavity arising from posterior fundal wall and extending into the vagina (Fig 4 and Fig 5) . The mass was hypointense on T1 weighted (T1Wt) images and heterogeneously hyperintense on T2Wt and fat suppressed T2Wt spectral attenuated inversion recovery (SPAIR) images. The uterine endo-myometrial junction was obscured (Fig 6) .
Posterior and lateral infiltration of the cervix and vaginal vault noted with a small extra-uterine component without pelvic wall or rectal involvement. Multiple linear hypointense bands noted within the mass on T2Wt images. The mass was hyperintense on diffusion weighted images (Fig 7a & 7b and Fig 8) . No pelvic lymphadenopathy was seen. Ultrasound of the abdomen did not reveal any liver lesions or abdominal lymphadenopathy. Contrast enhanced MRI was deferred due to CKD status (serum creatinine was 3.5mg/dl). Considering the rapid growth of the endometrial lesion within a span of 7 months, diagnosis of endometrial malignant neoplasm was made. The patient did not consent for further investigations or surgery and went against medical advice due to personal and financial reasons. Two weeks later she returned for surgery, however, her further investigations were restrained for financial reasons. Radical hysterectomy was performed and histopathology revealed poorly differentiated endometrial stromal sarcoma (Fig 9a, 9b  and Fig 10a, 10b) . During surgery, pelvic peritoneal nodularity was observed and subsequent non-contrast CT abdomen done for abdominal pain following surgery showed few peritoneal nodules (Fig 11) . Pelvic peritoneum was normal on initial MRI suggesting rapid spread and aggressive nature of the neoplasm.
The patient was referred to a tertiary oncology center for further chemoradiotherapy. Specific translocation t(7;17) (p15;q21) with the involvement of zinc finger genes juxtaposed with zinc finger proteins and chromosome deletion on 7p may play a role in the tumor development of ESS [5] . Risk factors include unopposed estrogens, exposure to tamoxifen and conditions like polycystic ovarian disease [5] .
Clinical & Imaging Findings:
ESS tumors may be asymptomatic at presentation or could present as postmenopausal or atypical premenopausal bleeding, [5, 6] , and rarely present with mass effect causing urinary and bowel obstructive symptoms.
Sonography usually demonstrates the endometrial mass. However, MRI is a more useful investigation because it helps in defining the local anatomy better, is able to differentiate benign versus malignant subtypes better, for suspecting the histologic subtype of the malignancy and for staging.
Sonographic findings are not characteristic and alone cannot definitively diagnose uterine sarcomas [7] . However, few studies have described four patterns on transvaginal sonography like diffuse myometrial thickening, central 
Treatment & Prognosis:
On review of available literature, the 10 year overall survival is 65-76% in low grade ESS and overall survival in UES is poor [13] .
Surgery and adjuvant hormonal therapy are the important elements in the treatment in ESS [14] . Hysterectomy along with bilateral salpingo-oophorectomy is the standard surgical treatment.
Low grade ESS is usually managed by cytoreductive surgery and hormonal treatment which include progestins and aromatase inhibitors as maintenance therapy. However, for High grade ESS; cytotoxic agents like doxorubicin and ifosfamide or gemcitabine with docetaxel and doxorubicin have been used prior to surgery for tumor shrinkage [12] .
In our case, the patient underwent radical hysterectomy with removal of uterus, cervix and part of the vagina. She was referred to a tertiary center following surgery for further treatment, after which she was lost to follow up. estrogen excess, and long term use of tamoxifen are the associated risk factors [15] . Sonography may demonstrate thickened endometrium and also the depth of myometrium and cervical invasion. It may mimic ESS due to the endomyometrial involvement. Endometrial carcinoma is isointense with normal endometrium and myometrium on T1Wt images and heterogeneous with variable appearance on T2Wt images [16] . Invasive ones show disruption or irregularity of the junctional zone on T2Wt images [16] 
Adenomyosis
Adenomyosis commonly affects multiparous and premenopausal women. Sonography demonstrates heterogeneity of the myometrium with small myometrial cysts, poorly defined endo-myometrial junction and ill-defined margins between the normal and abnormal myometrium [18] . Typical ones are ill-defined, T2 low signal intensity lesions with tiny cysts appearing as T2 bright spots. Junctional zone is thickened. Contrast enhancement is variable. DWI shows low to intermediate signal intensity [19] . Low grade ESS may occasionally be present within the myometrium mimicking adenomyosis.
Large malignant uterine tumors have varied presentation and have overlapping features due to endo-myometrial involvement. Few characteristic features, on Ultrasound and MRI, especially with T2Wt images, seen as hypointense bands within the tumor with the bag of worms appearance, give clues to consider endometrial stromal sarcoma as one of the differential diagnoses. 
Etiology
Origin is poorly understood. However, specific translocation t(7;17) (p15;q21) and chromosomal deletion on 7p may play a role in tumor development Incidence 0.2% of all uterine malignancies and 10-15% of all uterine mesenchymal malignancies Gender ratio
Only females Age predilection A low grade subtype of endometrial stromal sarcoma (ESS) presents at the mean age of 39 years High grade ESS presents at the mean age of 61 years
Risk factors
Exposure to tamoxifen, unopposed estrogens, and conditions such as polycystic disease of ovary Presentation Asymptomatic/post-menopausal bleeding/ atypical premenopausal bleeding / bladder -bowel symptoms due to extrinsic compression
Findings on imaging
Ultrasonography -Diffuse myometrial thickening, central cavity mass, mural mass and polypoidal mass protruding into the endometrial cavity from the myometrium are the four patterns described.
MRI -Heterogeneously isointense on T1 weighted and hyperintense on T2 weighted images. Low grade ESS may show myometrial involvement, giving rise to an appearance of bag of worms on T2 weighted images. High grade ESS shows peripheral hypointense rim and extensive necrosis.
Treatment
Surgery and adjuvant hormonal therapy.
Prognosis
Low grade ESS has a better prognosis than High grade ESS. 10yr overall survival is 65 -76% in Low grade ESS and overall survival is poor regardless of stage. 
